DrugPatentWatch Database Preview
Unichem Labs Ltd Company Profile
» See Plans and Pricing
What is the competitive landscape for UNICHEM LABS LTD, and what generic and branded alternatives to UNICHEM LABS LTD drugs are available?
UNICHEM LABS LTD has four approved drugs.
Drugs and US Patents for Unichem Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unichem Labs Ltd | TOPIRAMATE | topiramate | TABLET;ORAL | 090162-001 | Mar 27, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
Unichem Labs Ltd | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 091283-001 | Nov 28, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
Unichem Labs Ltd | DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 079163-003 | Apr 5, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.